Delivery Order SPE2DR25D1053-SPE2DR26FV686
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Fentanyl 100 micrograms per 2 milliliter vials at a ceiling value of $1,345.37. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion by December 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Fentanyl 100 mcg/2 ml vials. The $1,041.78 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense that manages medical supply chains. The contract has an ultimate completion date of November 29, 2024 and was awarded on November 27, 2024. This award is a delivery order under a larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Fentanyl 100 micrograms per 2 milliliter vials with a ceiling value of $1,327.86. This is a firm fixed-price delivery order with an ultimate completion date of July 17, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,419.18 to AmerisourceBergen Drug Corp for Fentanyl 100 MCG/25 units on December 22, 2025, with completion targeted for December 23, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,365.40 to AmerisourceBergen Drug Corp for Fentanyl 100 mcg/2 mL vials on July 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order is scheduled for completion by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 MCG/2 ML Vial 2ML, valued at $1,667.43. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,017.34 to AmerisourceBergen Drug Corp for the supply of Fentanyl 1,000 micrograms per 20 milliliter vials on October 24, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order was not set-aside and represents a competitive award issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,258.56 for Fentanyl 100 MCG/2 ML vials on September 9, 2025, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,201.32 firm fixed-price delivery order is for the supply of 4,566,243,239 units of 100 mcg/2 mL fentanyl vials. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 25, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,030.03 and is a firm fixed-price contract running through July 2024. The contract provides for the delivery of Fentanyl 100 mcg/2 mL vials to support U.S. government medical requirements. No set-aside designation was used. AmerisourceBergen holds a larger Indefinite Delivery...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV686Delivery Order
This delivery order, valued at $1,330.74, awards pharmaceutical supplies to AmerisourceBergen Drug Corp for the delivery of Fentanyl 100 micrograms per 2 milliliters in vial form. The contract was awarded on January 21, 2026, by the Defense Logistics Agency (DLA), a defense-focused federal agency responsible for supplying critical medical commodities to military healthcare systems. The award is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 22, 2026. Performance will take place at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, generic drugs, vaccines, and related medical commodities. AmerisourceBergen's role as a critical pharmaceutical distributor allows it to efficiently fulfill government contracts for essential medical products required by military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/20/26 |